Former Talaris Therapeutics facility in Louisville sold to New York biotech company


A Louisville biotech facility, once home to one of the region's most promising startups, has been sold.

Previous Community banks' biggest concerns? It starts with narrowing margins and shifts to new issues from there, survey finds
Next Exclusive: Handle Global raises more than $8 million